Cargando…

Pharmacogenomics Biomarkers of Soft Tissue Sarcoma Therapies

Soft tissue sarcomas (STS) are heterogeneous rare malignancies comprising ~1% of all solid cancers in adults and including more than 70 histological and molecular subtypes with different pathological and clinical development characteristics. Over the last two decades, the increased knowledge of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Caruso, Chiara, Garofalo, Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174622/
https://www.ncbi.nlm.nih.gov/pubmed/32351891
http://dx.doi.org/10.3389/fonc.2020.00509